GlaxoSmithKline Pharmaceuticals Limited (GLAXO) — Net Asset Quality Index
GlaxoSmithKline Pharmaceuticals Limited (GLAXO) has a Net Asset Quality Index of 46.6% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Rs36.65 Billion minus total liabilities of Rs19.57 Billion yields net assets of Rs17.08 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check GlaxoSmithKline Pharmaceuticals Limited (GLAXO) asset resilience to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
GlaxoSmithKline Pharmaceuticals Limited Net Asset Quality Index Over Time (2005–2025)
This chart shows how GlaxoSmithKline Pharmaceuticals Limited's Net Asset Quality Index has evolved across 21 annual periods from 2005 to 2025. As of September 2025, the index stands at 46.6%, representing net assets of Rs17.08 Billion against total assets of Rs36.65 Billion INR. See GLAXO net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for GlaxoSmithKline Pharmaceuticals Limited (2005–2025)
The table below presents the year-by-year Net Asset Quality Index for GlaxoSmithKline Pharmaceuticals Limited from 2005 to 2025, covering 21 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see GLAXO market cap overview.
| Year | Quality Index | Net Assets (INR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 47.5% | Rs19.51 Billion | Rs41.08 Billion | Rs21.57 Billion | ▼ -2.5 pp |
| 2024 | 50.0% | Rs17.78 Billion | Rs35.57 Billion | Rs17.79 Billion | ▼ -2.4 pp |
| 2023 | 52.3% | Rs17.41 Billion | Rs33.27 Billion | Rs15.85 Billion | ▼ -5.1 pp |
| 2022 | 57.5% | Rs26.63 Billion | Rs46.33 Billion | Rs19.70 Billion | ▲ +9.3 pp |
| 2021 | 48.1% | Rs14.99 Billion | Rs31.13 Billion | Rs16.14 Billion | ▼ -9.9 pp |
| 2020 | 58.1% | Rs18.21 Billion | Rs31.36 Billion | Rs13.15 Billion | ▲ +3.4 pp |
| 2019 | 54.7% | Rs21.40 Billion | Rs39.11 Billion | Rs17.71 Billion | ▲ +2.6 pp |
| 2018 | 52.1% | Rs20.57 Billion | Rs39.47 Billion | Rs18.90 Billion | ▼ -14.7 pp |
| 2017 | 66.8% | Rs20.07 Billion | Rs30.04 Billion | Rs9.97 Billion | ▲ +11.1 pp |
| 2016 | 55.7% | Rs16.96 Billion | Rs30.46 Billion | Rs13.50 Billion | ▼ -20.1 pp |
| 2015 | 75.8% | Rs24.44 Billion | Rs32.24 Billion | Rs7.80 Billion | ▲ +12.2 pp |
| 2014 | 63.6% | Rs19.90 Billion | Rs31.30 Billion | Rs11.40 Billion | ▼ -1.4 pp |
| 2013 | 65.0% | Rs20.07 Billion | Rs30.88 Billion | Rs10.82 Billion | ▲ +1.8 pp |
| 2012 | 63.1% | Rs19.36 Billion | Rs30.66 Billion | Rs11.30 Billion | ▼ -6.3 pp |
| 2011 | 69.4% | Rs19.52 Billion | Rs28.10 Billion | Rs8.59 Billion | ▼ -2.1 pp |
| 2010 | 71.5% | Rs17.86 Billion | Rs24.98 Billion | Rs7.12 Billion | ▲ +3.6 pp |
| 2009 | 67.9% | Rs15.76 Billion | Rs23.21 Billion | Rs7.45 Billion | ▲ +0.1 pp |
| 2008 | 67.8% | Rs13.81 Billion | Rs20.36 Billion | Rs6.55 Billion | ▲ +0.5 pp |
| 2007 | 67.3% | Rs12.05 Billion | Rs17.89 Billion | Rs5.84 Billion | ▲ +4.5 pp |
| 2006 | 62.9% | Rs9.53 Billion | Rs15.16 Billion | Rs5.63 Billion | ▼ -2.5 pp |
| 2005 | 65.3% | Rs9.24 Billion | Rs14.14 Billion | Rs4.90 Billion | — |